These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10716945)

  • 1. Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.
    Puri PL; Wu Z; Zhang P; Wood LD; Bhakta KS; Han J; Feramisco JR; Karin M; Wang JY
    Genes Dev; 2000 Mar; 14(5):574-84. PubMed ID: 10716945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
    Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
    Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor.
    Zetser A; Gredinger E; Bengal E
    J Biol Chem; 1999 Feb; 274(8):5193-200. PubMed ID: 9988769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase.
    Li Y; Jiang B; Ensign WY; Vogt PK; Han J
    Cell Signal; 2000 Dec; 12(11-12):751-7. PubMed ID: 11152961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells.
    Morooka T; Nishida E
    J Biol Chem; 1998 Sep; 273(38):24285-8. PubMed ID: 9733710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
    Wu Z; Woodring PJ; Bhakta KS; Tamura K; Wen F; Feramisco JR; Karin M; Wang JY; Puri PL
    Mol Cell Biol; 2000 Jun; 20(11):3951-64. PubMed ID: 10805738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells.
    Mauro A; Ciccarelli C; De Cesaris P; Scoglio A; Bouché M; Molinaro M; Aquino A; Zani BM
    J Cell Sci; 2002 Sep; 115(Pt 18):3587-99. PubMed ID: 12186945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
    Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
    McDermott EP; O'Neill LA
    J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells.
    Ostrovsky O; Bengal E; Aronheim A
    J Biol Chem; 2002 Oct; 277(42):40043-54. PubMed ID: 12171923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation.
    Lee J; Hong F; Kwon S; Kim SS; Kim DO; Kang HS; Lee SJ; Ha J; Kim SS
    Biochem Biophys Res Commun; 2002 Nov; 298(5):765-71. PubMed ID: 12419320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.
    Deacon K; Blank JL
    J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells.
    Zhen X; Uryu K; Wang HY; Friedman E
    Mol Pharmacol; 1998 Sep; 54(3):453-8. PubMed ID: 9730903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p38 pathway provides negative feedback for Ras proliferative signaling.
    Chen G; Hitomi M; Han J; Stacey DW
    J Biol Chem; 2000 Dec; 275(50):38973-80. PubMed ID: 10978313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2.
    Chen Z; Cobb MH
    J Biol Chem; 2001 May; 276(19):16070-5. PubMed ID: 11279118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest.
    Takenaka K; Moriguchi T; Nishida E
    Science; 1998 Apr; 280(5363):599-602. PubMed ID: 9554853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.
    Nagata Y; Todokoro K
    Blood; 1999 Aug; 94(3):853-63. PubMed ID: 10419875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.
    Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F
    Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
    Alexander LD; Cui XL; Falck JR; Douglas JG
    Kidney Int; 2001 Jun; 59(6):2039-53. PubMed ID: 11380805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat.
    Maizels ET; Mukherjee A; Sithanandam G; Peters CA; Cottom J; Mayo KE; Hunzicker-Dunn M
    Mol Endocrinol; 2001 May; 15(5):716-33. PubMed ID: 11328854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.